Skip to content

A bioluminescent indicator glows when a cancer drug is active inside the brain, identifying which medications cross the blood-brain barrier.

A bioluminescent indicator glows when a cancer drug is active inside the brain, identifying which medications cross the blood-brain barrier.

Researchers from Stanford have developed a wearable sensor to monitor the size of tumors, which could assist new cancer drug evaluations.

Researchers from Stanford have developed a wearable sensor to monitor the size of tumors, which could assist new cancer drug evaluations.

Published on

Researchers are harnessing an imaging technique called cryogenic electron microscopy to design drugs and better understand disease.

Researchers are harnessing an imaging technique called cryogenic electron microscopy to design drugs and better understand disease.

Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.

Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.

Researchers at Stanford Medicine are working to develop antivirals to stop the current pandemic and prevent ones.

Researchers at Stanford Medicine are working to develop antivirals to stop the current pandemic and prevent ones.

Published on

Stanford researchers are developing a faster way to match each ulcerative colitis patient with the treatment that will work best for them.

Stanford researchers are developing a faster way to match each ulcerative colitis patient with the treatment that will work best for them.

Researchers discuss the need for ethics and its integration into research projects that harness artificial intelligence.

Researchers discuss the need for ethics and its integration into research projects that harness artificial intelligence.

A Stanford patient improved greatly after being the first person with sight-threatening thyroid eye disease to receive the drug teprotumumab.

A Stanford patient improved greatly after being the first person with sight-threatening thyroid eye disease to receive the drug teprotumumab.

To help us understand muscle loss as we age, a Stanford Medicine research team’s engineered tissue is sent to the International Space Station.

To help us understand muscle loss as we age, a Stanford Medicine research team’s engineered tissue is sent to the International Space Station.

Published on

Anthony Oro is devoted to understanding the origin of basal cell carcinomas. Now he's found how some become resistant to a common treatment.

Anthony Oro is devoted to understanding the origin of basal cell carcinomas. Now he's found how some become resistant to a common treatment.

Stanford Medicine researchers have discovered a drug that could potentially be used to stave off SARS-CoV-2, the virus that causes COVID-19.

Stanford Medicine researchers have discovered a drug that could potentially be used to stave off SARS-CoV-2, the virus that causes COVID-19.

Published on

A study provides evidence that the drug azlocillin eliminates the bacteria that cause Lyme disease at the onset of infection in lab mice and cultures.

A study provides evidence that the drug azlocillin eliminates the bacteria that cause Lyme disease at the onset of infection in lab mice and cultures.

Published on